17.02.2010 21:15:00

Celera Corporation Fourth Quarter and 2009 Results and Conference Call Scheduled for March 3, 2010

Celera Corporation (NASDAQ:CRA) announced today that it will issue fourth quarter and 2009 financial results on Wednesday, March 3, 2010. Results are scheduled for release after the close of trading on the NASDAQ stock market. Kathy Ordoñez, Chief Executive Officer, and Ugo DeBlasi, Chief Financial Officer, will lead a conference call the same day at 4:30 p.m. (ET) to discuss these results and other matters related to the business.

The management team will make prepared remarks and answer questions from securities analysts and investment professionals. Investors, securities analysts, representatives of the media and other interested parties who would like to participate should dial (800) 510-0219, or (617) 614-3451 for international callers, and enter passcode 91540609 at any time from 4:15 p.m. (ET) until the end of the call. This conference call will also be webcast. Interested parties who wish to listen to the webcast should visit the "Media and Investors” section on www.celera.com. A digital recording will be available approximately two hours after the completion of the conference call on March 3 until March 10, 2010. Interested parties should call (888) 286-8010, or (617) 801-6888 for international callers, and enter passcode 21619664.

About Celera

Celera is a healthcare business focusing on the integration of genetic testing into routine clinical care through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer. Information about Celera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.celera.com.

Copyright© 2010. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Applera Corp. - Celera Genomics Groupmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Applera Corp. - Celera Genomics Groupmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 19 060,48 -0,60%